NASDAQ · BIB
ProShares Ultra Nasdaq Biotechnology
$120.53+$0.00 (0.0%)
ProShares Ultra Nasdaq Biotechnology’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
Loading market information…
AMEX · UPAR · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:50 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
UPAR Ultra Risk Parity ETF’s quoted price sits in the lower half of its reported 52-week range, 14.12% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
UPAR Ultra Risk Parity ETF’s forward annual dividend is $0.44 per share, paid quarterly. The forward yield is 2.86% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This ETF utilizes a risk parity investment approach comparable to RPAR, but it is structured to aim for enhanced returns by accepting an amplified risk profile. Its investment strategy involves prudently spreading capital across four distinct market segments: corporate stocks, raw materials, government debt instruments, and Treasury Inflation-Protected Securities (TIPS).
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 04:12 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$120.53+$0.00 (0.0%)
ProShares Ultra Nasdaq Biotechnology’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
$36.40-$0.34 (-0.93%)
iShares LifePath Target Date 2035 ETF’s quoted price sits in the upper half of its reported 52-week range, 3.09% below the high.
$42.76-$0.55 (-1.28%)
BNY Mellon US Small Cap Core Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 7.1% below the high.
$37.29-$1.07 (-2.8%)
Rareview Systematic Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 7.65% below the high.
$59.25-$1.55 (-2.55%)
Impact Shares NAACP Minority Empowerment ETF’s quoted price sits in the upper half of its reported 52-week range, 5.96% below the high.
$33.84-$0.48 (-1.4%)
Franklin FTSE Eurozone ETF’s quoted price sits in the lower half of its reported 52-week range, 9.64% below the high.
$35.15+$0.06 (+0.16%)
Cambiar Aggressive Value ETF’s quoted price sits in the upper half of its reported 52-week range, 3.17% below the high.
$24.13-$0.06 (-0.23%)
Discipline Fund ETF’s quoted price sits in the upper half of its reported 52-week range, 1.29% below the high.
